Drug Maker, Teva, Recalls Parkinson?s Disease Medication as it may be ?Super Potent? | NewsInferno
At Wednesday's meeting, Prayuth dismissed allegations of abuse in military custody. "In case you have heard distorted information that we have treated people badly, it is not true. Just look at my face. I am not a cruel person." Thailand's economy, which narrowly avoided a technical recession in the second quarter this year, is struggling to get back on its feet after months of sometimes violent street demonstrations that left nearly 30 people dead. A regional hub and export base for global automakers, Thailand is looking to revive domestic consumption and investment following months of political turmoil that have tested its "Teflon Thailand" moniker. WEAK EXPORTS Exports, equal to more than 60 percent of the economy, remain weak.
For the original version including any supplementary images or video, visit http://news.yahoo.com/thai-premier-tells-foreign-investors-not-dictators-112852364--business.html
Teva Pharmaceutical Industries indicated that the recall, which has been deemed a Class II, involved 3,881 bottles of carbidopa/levodopa 25 mg/100 mg, according to FiercePharmaManufacturing. Teva also indicated that stability testing revealed that the recalled carbidopa/levodopa may be what the drug maker described as super potent. The voluntary recall is for the entire United States. According to the U.S. Food and Drug Administration (FDA), the lot number involved is 29C220 and the expiry date is 11/15. Teva Pharmaceutical Industries, which is based in Israel, has experienced numerous and significant recalls in 2014. For example, in June 2014, the drug maker announced a recall of nearly 130,000 cartons of Tev-Tropin human growth hormone for children over concerns that oil leaked into the medication, according to FiercePharmaManufacturing. Prior to that, in April, Teva issued another recall of more than 1 million bottles of its then-released generic version of Eli Lillys antidepressant, Cymbalta. Now, Teva Pharmaceutical Industries is conducting massive restructuring and seeks to cut some $2 billion in costs, FiercePharmaManufacturing reported.
For the original version including any supplementary images or video, visit http://www.newsinferno.com/drug-maker-teva-recalls-parkinsons-disease-medication-as-it-may-be-super-potent/